These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 15310279)

  • 21. Inhibition of the protease activity of influenza virus RNA polymerase PA subunit by viral matrix protein.
    Hara K; Shiota M; Kido H; Watanabe K; Nagata K; Toyoda T
    Microbiol Immunol; 2003; 47(7):521-6. PubMed ID: 12953845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and characterization of mutations conferring resistance to an HCV RNA-dependent RNA polymerase inhibitor in vitro.
    Lu L; Dekhtyar T; Masse S; Pithawalla R; Krishnan P; He W; Ng T; Koev G; Stewart K; Larson D; Bosse T; Wagner R; Pilot-Matias T; Mo H; Molla A
    Antiviral Res; 2007 Oct; 76(1):93-7. PubMed ID: 17561278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Production and characterization of active hepatitis C virus RNA-dependent RNA polymerase.
    Ryu K; Kim KH; Yoo SY; Lee EY; Lim KH; Min MK; Kim H; Choi SI; Seong BL
    Protein Expr Purif; 2010 Jun; 71(2):147-52. PubMed ID: 20060472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modification of hepatitis C virus 1b RNA polymerase to make a highly active JFH1-type polymerase by mutation of the thumb domain.
    Weng L; Du J; Zhou J; Ding J; Wakita T; Kohara M; Toyoda T
    Arch Virol; 2009; 154(5):765-73. PubMed ID: 19340394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-nucleoside inhibitors of the HCV polymerase.
    Sarisky RT
    J Antimicrob Chemother; 2004 Jul; 54(1):14-6. PubMed ID: 15190019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel protease and polymerase inhibitors for the treatment of hepatitis C virus infection.
    Sheldon J; Barreiro P; Soriano V
    Expert Opin Investig Drugs; 2007 Aug; 16(8):1171-81. PubMed ID: 17685867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B-ring modified aurones as promising allosteric inhibitors of hepatitis C virus RNA-dependent RNA polymerase.
    Meguellati A; Ahmed-Belkacem A; Yi W; Haudecoeur R; Crouillère M; Brillet R; Pawlotsky JM; Boumendjel A; Peuchmaur M
    Eur J Med Chem; 2014 Jun; 80():579-92. PubMed ID: 24835816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydrophobic and charged residues in the C-terminal arm of hepatitis C virus RNA-dependent RNA polymerase regulate initiation and elongation.
    Cherry AL; Dennis CA; Baron A; Eisele LE; Thommes PA; Jaeger J
    J Virol; 2015 Feb; 89(4):2052-63. PubMed ID: 25428878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant RNA-Dependent RNA Polymerase Complex of Ebola Virus.
    Tchesnokov EP; Raeisimakiani P; Ngure M; Marchant D; Götte M
    Sci Rep; 2018 Mar; 8(1):3970. PubMed ID: 29507309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis C virus RNA-dependent RNA polymerase: study on the inhibition mechanism by pyrogallol derivatives.
    Kozlov MV; Polyakov KM; Ivanov AV; Filippova SE; Kuzyakin AO; Tunitskaya VL; Kochetkov SN
    Biochemistry (Mosc); 2006 Sep; 71(9):1021-6. PubMed ID: 17009957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of natural polymorphisms in SARS-CoV-2 RNA-dependent RNA polymerase on its activity and sensitivity to inhibitors in vitro.
    Miropolskaya N; Kozlov M; Petushkov I; Prostova M; Pupov D; Esyunina D; Kochetkov S; Kulbachinskiy A
    Biochimie; 2023 Mar; 206():81-88. PubMed ID: 36252889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Label free inhibitor screening of hepatitis C virus (HCV) NS5B viral protein using RNA oligonucleotide.
    Roh C; Kim SE; Jo SK
    Sensors (Basel); 2011; 11(7):6685-96. PubMed ID: 22163979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resistance to HCV nucleoside analogue inhibitors of hepatitis C virus RNA-dependent RNA polymerase.
    Najera I
    Curr Opin Virol; 2013 Oct; 3(5):508-13. PubMed ID: 24070806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of Potent Non-nucleoside Inhibitors of Dengue Viral RNA-Dependent RNA Polymerase from Fragment Screening and Structure-Guided Design.
    Lim SP; Noble CG; Nilar S; Shi PY; Yokokawa F
    Adv Exp Med Biol; 2018; 1062():187-198. PubMed ID: 29845534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New non-nucleoside inhibitors of hepatitis C virus RNA-dependent RNA polymerase.
    Ivanov AV; Kozlov MV; Kuzyakin AO; Kostyuk DA; Tunitskaya VL; Kochetkov SN
    Biochemistry (Mosc); 2004 Jul; 69(7):782-8. PubMed ID: 15310279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-hepatitis C virus RdRp activity and replication of novel anilinobenzothiazole derivatives.
    Peng HK; Chen WC; Lin YT; Tseng CK; Yang SY; Tzeng CC; Lee JC; Yang SC
    Antiviral Res; 2013 Oct; 100(1):269-75. PubMed ID: 23994188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A fluorescence-based high-throughput screen to identify small compound inhibitors of the genotype 3a hepatitis C virus RNA polymerase.
    Eltahla AA; Lackovic K; Marquis C; Eden JS; White PA
    J Biomol Screen; 2013 Oct; 18(9):1027-34. PubMed ID: 23708123
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.